FDA approves H1N1 swine flu vaccines

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American



On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The U.S. Food and Drug Administration approved the long-awaited vaccines for the H1N1 "swine" flu virus this afternoon. It is expected to be available in a month at about 90,000 locations nationwide, the Associated Press reported

"We will have enough vaccine available for everyone," Kathleen Sebelius, Health and Human Services Secretary, said in an address to Congress today, the AP reports. The government, which does not expect everyone to get the vaccine, has an order out for 195 million doses, but only about 45 million are expected to be available by mid-October. The announcement from the National Institutes of Health (NIH) last week that one dose is sufficient to protect against the virus means supplies will be more robust than they might otherwise have been. Nevertheless, the government is prepared to order more if necessary.

The vaccines, which have been in clinical studies in the U.S. since June, are made by four different firms.

"The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines," Jesse Goodman, acting chief scientist at the FDA, said in a prepared statement.

Given the initially limited availability of the vaccine, the government still recommends that those who are most likely to have complications from the flu, including children and pregnant women, should be the first in line for the shots.

At least one million people in the U.S. have likely been infected with the virus since April, according to the Centers for Disease Control (CDC), and 593 people have died, including about 40 children. The seasonal flu infects from 5 to 20 percent of the U.S. population every year and kills about 36,000, according to the CDC. Unlike the seasonal flu, the H1N1 swine flu virus has been found to be contagious for about a week after symptoms have receded. Researchers are recommending people with the flu stay home for several days even after they start feeling better.

Image courtesy of iStockphoto/VCTStyle

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe